tiprankstipranks
Trending News
More News >
Quick Heal Technologies Ltd. (IN:QUICKHEAL)
:QUICKHEAL
India Market

Quick Heal Technologies Ltd. (QUICKHEAL) AI Stock Analysis

Compare
2 Followers

Top Page

IN:QUICKHEAL

Quick Heal Technologies Ltd.

(QUICKHEAL)

Select Model
Select Model
Select Model
Neutral 41 (OpenAI - 5.2)
Rating:41Neutral
Price Target:
₹159.00
▼(-40.85% Downside)
Action:ReiteratedDate:01/31/26
The score is held down primarily by weakening financial performance (declining revenue, negative operating profitability, and negative operating/free cash flow) and poor technicals (price below key moving averages with negative MACD and very weak RSI/Stoch). Valuation further pressures the score due to an extremely high P/E, with only limited offset from the dividend yield and a strong low-debt balance sheet.
Positive Factors
Conservative balance sheet / low leverage
Minimal leverage and a sizable equity base provide durable financial flexibility. With debt near zero the company can absorb short-term cash stress, fund product investments or marketing, and avoid refinancing risk—supporting stability over the next several quarters.
Recurring licensing and channel-led revenue model
A subscription/license model with renewals and a broad channel/reseller network creates recurring revenue and stickiness. This structural mix improves predictability of cashflows and supports retention-led growth if renewal rates and channel execution hold.
High gross margins and prior cash generation history
Sustained high gross margins indicate inherent product economics and pricing power; combined with a track record of positive operating cash flow in prior years, this suggests the company can restore profitable cash generation if it regains operating leverage.
Negative Factors
Revenue decline and compressing margins
Falling revenue and sharply weaker operating profitability signal demand or competitive pressure and reduce room to absorb fixed costs. Persistent top-line weakness undermines margin recovery and could force structural cost or product strategy changes over multiple quarters.
Negative operating and free cash flow in FY2025
A reversal to negative OCF and FCF increases execution risk and limits reinvestment capacity. Even with low leverage, sustained cash burn can necessitate spending cuts, slower product development, or outside financing, all of which impair strategic flexibility.
Weaker returns on capital and operating leverage erosion
A ROE near 1% and deteriorated operating margins indicate the firm is struggling to convert assets and revenue into shareholder returns. This suggests structural margin pressure or cost inefficiencies that may take multiple quarters to correct.

Quick Heal Technologies Ltd. (QUICKHEAL) vs. iShares MSCI India ETF (INDA)

Quick Heal Technologies Ltd. Business Overview & Revenue Model

Company DescriptionQuick Heal Technologies Limited provides security software products and solutions to consumers, small businesses, government establishments, and corporate houses in India and internationally. The company operates through Retail, Enterprise and Government, and Mobile segments. Its products portfolio includes GoDeep.AI, a malware hunting engine; Seqrite Hawk, a cybersecurity solution; and Hawk Eye, a cloud-based platform for enterprise grade centralized security management. The company also offers technical and after-sales support services. It sells its products through a network of service providers, system integrators, resellers, and distributors. The company offers its products under Seqrite brand. Quick Heal Technologies Limited was incorporated in 1995 and is based in Pune, India.
How the Company Makes Money

Quick Heal Technologies Ltd. Financial Statement Overview

Summary
Despite a strong, low-debt balance sheet (Balance Sheet Score 86), fundamentals have weakened: revenue declined in FY2025 and profitability deteriorated to negative EBIT/EBITDA margins with a much lower net margin (Income Statement Score 41). Cash generation is a key risk, with FY2025 operating cash flow and free cash flow turning negative (Cash Flow Score 33).
Income Statement
41
Neutral
Revenue has been largely flat to down recently, with FY2025 showing a ~5.1% decline versus FY2024. Profitability has weakened materially: FY2025 posted negative EBIT and EBITDA margins while net margin compressed to ~1.8% (down from ~8.3% in FY2024). The business still shows very high gross margin in FY2025, but the sharp deterioration at the operating line suggests elevated operating costs and weaker operating leverage, creating an uneven earnings profile versus the stronger profitability seen in earlier years (FY2020–FY2021).
Balance Sheet
86
Very Positive
The balance sheet is conservatively structured with minimal leverage (debt-to-equity near zero; FY2025 debt is negligible relative to equity). Equity remains sizable and assets are stable, which supports financial flexibility. The main drawback is softer returns on equity in the most recent year (FY2025 ROE ~1.1%), reflecting the weaker earnings base rather than balance-sheet strain.
Cash Flow
33
Negative
Cash generation has weakened meaningfully: FY2025 operating cash flow and free cash flow were both negative, a sharp reversal from positive cash generation in FY2024 and earlier years. This raises questions around working-capital/investment demands and the quality/consistency of earnings conversion. While cash flow was healthy historically (FY2020–FY2022), the latest year’s cash burn increases near-term execution risk until cash generation stabilizes.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue2.66B2.80B2.92B2.78B3.42B3.33B
Gross Profit2.63B2.72B1.17B1.14B1.92B2.04B
EBITDA25.00M-65.90M373.00M227.70M1.07B1.45B
Net Income-45.00M50.40M242.40M64.00M831.90M1.07B
Balance Sheet
Total Assets0.005.25B5.13B4.93B7.16B8.27B
Cash, Cash Equivalents and Short-Term Investments1.93B1.93B2.20B1.88B3.54B4.67B
Total Debt0.003.10M0.000.000.000.00
Total Liabilities-4.41B835.60M756.30M735.90M882.50M752.10M
Stockholders Equity4.41B4.41B4.37B4.20B6.28B7.51B
Cash Flow
Free Cash Flow0.00-367.20M106.30M267.30M741.30M897.60M
Operating Cash Flow0.00-223.00M181.90M308.10M799.80M986.20M
Investing Cash Flow0.00159.70M61.50M1.85B1.26B-922.90M
Financing Cash Flow0.00-103.20M16.00M-2.12B-2.14B1.00M

Quick Heal Technologies Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
₹21.59B2.67
68
Neutral
₹18.78B14.180.42%21.17%27.66%
66
Neutral
₹18.12B34.33155.87%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
54
Neutral
₹10.92B52.860.55%11.73%-64.05%
46
Neutral
₹5.14B508.33-9.53%96.99%
41
Neutral
₹9.00B156.861.08%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:QUICKHEAL
Quick Heal Technologies Ltd.
166.05
-112.95
-40.48%
IN:BCG
Brightcom Group Limited
10.70
0.42
4.09%
IN:IKIO
IKIO Lighting Limited
141.35
-65.85
-31.78%
IN:KERNEX
Kernex Microsystems India Ltd.
1,078.55
228.25
26.84%
IN:SAKSOFT
Saksoft Limited
141.70
-17.39
-10.93%
IN:SUBEXLTD
Subex Limited
9.15
-4.07
-30.79%

Quick Heal Technologies Ltd. Corporate Events

Quick Heal Board Clears Q3 FY26 Results, Senior Leadership Overhaul and Promoter Reclassification
Jan 29, 2026

Quick Heal Technologies Ltd. said its board has approved the unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2025, along with the related limited review reports from its statutory auditors. The board also cleared several senior management changes, appointing Savita Nehra as Vice President – People and Culture, Amartya Mukherjee as Vice President and Head of Delivery, promoting Netra Deshpande to Head of Engineering, and appointing Nitin Bhogan as Director – Cyber Awareness, moves that signal a strengthening of leadership across key operational and technical functions. In addition, the board approved a request from Gagan Bharari Enterprises LLP to be reclassified from the Promoter and Promoter Group category to Public Shareholders, subject to stock exchange approvals, a shift that could modestly alter the company’s shareholding structure and float.

Quick Heal Board Clears Q3 FY26 Results, Strengthens Leadership and Backs Promoter Reclassification
Jan 29, 2026

Quick Heal Technologies Ltd. said its board, meeting via video conference on January 29, 2026, approved the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, along with the statutory auditors’ limited review reports, and released an accompanying press note and investor presentation. The board also strengthened its senior leadership bench with the appointment of new vice presidents for people and culture and for delivery, the promotion of a new head of engineering, and the appointment of a director for cyber awareness, while additionally backing the reclassification request of Gagan Bharari Enterprises LLP from ‘promoter and promoter group’ to ‘public shareholder’ status, subject to stock exchange approval, a move that could modestly alter the company’s shareholding structure and public float.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 31, 2026